Phospholipase and proteinase activities of Candida isolates from denture wearers

Mycoses

Volumn 54, Issue 4, 2011, Pages

  Marcos Arias, Cristina ^a   Eraso, Elena ^a   Madariaga, Lucila ^a   Aguirre, Jose Manuel ^a   Quindós, Guillermo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Candida; Denture; Oral; Phospholipase; Proteinase; Stomatitis

Indexed keywords

AGAR; PHOSPHOLIPASE; PROTEINASE; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHI SQUARE TEST; CONTROLLED STUDY; DENTURE; DENTURE WEARER; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STOMATITIS; TOOTH PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; CANDIDA; DENTURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MYCOLOGY; PEPTIDE HYDROLASES; PHOSPHOLIPASES; SACCHAROMYCES CEREVISIAE; STOMATITIS, DENTURE;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS; PICHIA GUILLIERMONDII; SACCHAROMYCES CEREVISIAE;

EID: 79959275309     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01812.x     Document Type: Article

References (46)

1. Aguirre JM. Oral candidiasis. Rev Iberoam Micol 2002; 19: 17-21 (In Spanish).
2. Budtz-Jorgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 1990; 48: 61-9.
3. Barbeau J, Seguin J, Goulet JP et al. Reassessing the presence of Candida albicans in denture-related stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 51-9.
4. Budtz-Jorgensen E. The significance of Candida albicans in denture stomatitis. Scand J Dent Res 1974; 82: 151-90.
5. Iacopino AM, Wathen WF. Oral candidal infection and denture stomatitis: a comprehensive review. J Am Dent Assoc 1992; 123: 46-51.
6. Radford DR, Challacombe SJ, Walter JD. Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. Crit Rev Oral Biol Med 1999; 10: 99-116.
7. Ramage G, Tomsett K, Wickes BL, Lopez-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 53-9.
8. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J 1998; 43: 45-50.
9. Marcos-Arias C, Vicente JL, Sahand IH et al. Isolation of Candida dubliniensis in denture stomatitis. Arch Oral Biol 2009; 54: 127-31.
10. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187-218.
11. Kadir T, Gumru B, Uygun-Can B. Phospholipase activity of Candida albicans isolates from patients with denture stomatitis: the influence of chlorhexidine gluconate on phospholipase production. Arch Oral Biol 2007; 52: 691-6.
12. Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE, Fonseca PA, Figueiral MH. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals. J Oral Pathol Med 2008; 37: 587-92.
13. Thiele MC, Carvalho AD, Gursky LC, Rosa RT, Samaranayake LP, Rosa EA. The role of candidal histolytic enzymes on denture-induced stomatitis in patients living in retirement homes. Gerodontology 2008; 25: 229-36.
14. Eraso E, Moragues MD, Villar-Vidal M et al. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 2006; 44: 3340-5.
15. Eraso E, Sahand IH, Villar-Vidal M et al. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol 2006; 44: 611-5.
16. Cuétara MS, Alhambra A, Del Palacio A. Traditional microbiological diagnosis for invasive candidiasis in critical non-neutropenic patients. Rev Iberoam Micol 2006; 23: 4-7 (In Spanish).
17. Freydiere AM, Guinet R, Boyron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001; 39: 9-33.
18. Baires-Varguez L, Cruz-Garcia A, Villa-Tanaka L et al. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol 2007; 24: 148-51.
19. Cardenes-Perera CD, Torres-Lana A, Alonso-Vargas R et al. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis. Diagn Microbiol Infect Dis 2004; 50: 219-21.
20. Quindós G, Pontón J. Oral candidiasis: etiology, pathogenesis and laboratory diagnosis. Med Oral 1996; 1: 85-95.
21. Kanbe T, Arishima T, Horii T, Kikuchi A. Improvements of PCR-based identification targeting the DNA topoisomerase II gene to determine major species of the opportunistic fungi Candida and Aspergillus fumigatus. Microbiol Immunol 2003; 47: 631-8.
22. Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 2002; 40: 2860-5.
23. Polak A. Virulence of Candida albicans mutants. Mycoses 1992; 35: 9-16.
24. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
25. Cassone A, De Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987; 156: 777-83.
26. Ombrella AM, Racca L, Ramos L. Protease and phospholipase activities of Candida albicans isolated from vaginal secretions with different pH values. Rev Iberoam Micol 2008; 25: 12-6.
27. Basu S, Gugnani HC, Joshi S, Gupta N. Distribution of Candida species in different clinical sources in Delhi, India, and proteinase and phospholipase activity of Candida albicans isolates. Rev Iberoam Micol 2003; 20: 137-40.
28. Chakrabarti A, Nayak N, Talwar P. In vitro proteinase production by Candida species. Mycopathologia 1991; 114: 163-8.
29. Mohan das V, Ballal M. Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood. Rev Iberoam Micol 2008; 25: 208-10.
30. Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 2002; 45: 160-5.
31. Williamson MI, Samaranayake LP, MacFarlane TW. Phospholipase activity as a criterion for biotyping Candida albicans. J Med Vet Mycol 1986; 24: 415-7.
32. Bosco VL, Birman EG, Cury AE, Paula CR. Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance. Pesqui Odontol Bras 2003; 17: 217-22.
33. Hannula J, Saarela M, Dogan B et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol 2000; 15: 238-44.
34. Gumru B, Kadir T, Uygun-Can B, Ozbayrak S. Distribution and phospholipase activity of Candida species in different denture stomatitis types. Mycopathologia 2006; 162: 389-94.
35. Anil S, Samaranayake LP. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis. Chemotherapy 2003; 49: 243-7.
36. Galan-Ladero MA, Blanco MT, Sacristan B, Fernandez-Calderon MC, Perez-Giraldo C, Gomez-Garcia AC. Enzymatic activities of Candida tropicalis isolated from hospitalized patients. Med Mycol 2009; 1-4 (DOI:). [Epub ahead of print].
37. Echevarria A, Durante AG, Arechavala A, Negroni R. Comparative study of two culture media for the detection of phospholipase activity of Candida albicans and Cryptococcus neoformans strains. Rev Iberoam Micol 2002; 19: 95-8 (In Spanish).
38. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122-43.
39. Vidotto V, Ponton J, Aoki S et al. Differences in extracellular enzymatic activity between Candida dubliniensis and Candida albicans isolates. Rev Iberoam Micol 2004; 21: 70-4.
40. Bennett DE, McCreary CE, Coleman DC. Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans. Microbiology 1998; 144(Pt1): 55-72.
41. Koga-Ito CY, Lyon JP, Vidotto V, de Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 2006; 161: 219-23.
42. Lermann U, Morschhauser J. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 2008; 154: 3281-95.
43. Naglik JR, Moyes D, Makwana J et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008; 154: 3266-80.
44. Odds FC. Secreted proteinases and Candida albicans virulence. Microbiology 2008; 154: 3245-6.
45. Collin HL, Sorsa T, Meurman JH et al. Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000; 35: 259-65.
46. Manfredi M, McCullough MJ, Al-Karaawi ZM, Vescovi P, Porter SR. In vitro evaluation of virulence attributes of Candida spp. isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol 2006; 21: 183-9.